Results 221 to 230 of about 55,959 (291)

Association between Tpeak-Tend interval and QT prolongation: A study of sertindole and sotalol [PDF]

, 2018
Saeed Shakibfar, Johannes J. Struijk, Jørgen K. Kanters, Jimmi Nielsen, Samuel Emil Schmidt, Claus Graff   +5 more
openalex   +1 more source

Drug-induced QT interval prolongation: mechanisms and clinical management

Therapeutic Advances in Drug Safety, 2012
S. Nachimuthu, M. Assar, J. Schussler
semanticscholar   +1 more source

The Effects of Acute Hospitalisation on the Characteristics of Acute Sarcopenia in Older Adults: A Systematic Review and Meta‐Analysis

JCSM Communications, Volume 9, Issue 1, January/June 2026.
ABSTRACT Background Acute sarcopenia in hospitalised older adults is associated with poor outcomes, such as functional decline, increased risk of falls and prolonged hospital stays. Despite this, its development among older inpatients remains poorly understood.
Thomas J. Cartledge, Qian Yue Tan, Liam Jones, Taeko Becque, Kinda Ibrahim, Stephen Eu Ruen Lim   +5 more
wiley   +1 more source

Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancer. [PDF]

J Pharm Health Care Sci
Yokota H, Asahi R, Akamine Y, Kobayashi M, Wakabayashi H, Sakamoto S, Okuda Y, Sato K, Nakayama K, Kikuchi M.   +9 more
europepmc   +1 more source

Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes.

Europace, 2007
C. Antzelevitch
semanticscholar   +1 more source

Ivabradine Preserves Cardiac Structure and Reduces Cell Death in Four Dogs With Preclinical Mitral Valve Disease

Veterinary Medicine and Science, Volume 12, Issue 1, January 2026.
Reduces cardiac remodelling and apoptosis in dogs with MMVD stage B2: Long‐term treatment with ivabradine in dogs with asymptomatic myxomatous mitral valve disease (MMVD) stage B2 reduced heart rate without impairing cardiac function. ABSTRACT Background Ivabradine, a specific funny channel blocker, has shown cardiovascular benefits in humans and ...
Prapawadee Pirintr, Vudhiporn Limprasutr, Anudep Rungsipipat, Kasem Rattanapinyopituk, Suwanakiet Sawangkoon, Nakkawee Saengklub, Anusak Kijtawornrat   +6 more
wiley   +1 more source

QT interval prolongation from antipsychotics in schizophrenia and acute psychosis - A prospective study.

Ind Psychiatry J
Saha A, Kumar A, Singh S, Somani A.
europepmc   +1 more source

Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research

Andrology, Volume 14, Issue 1, Page 294-302, January 2026.
Abstract Introduction Testosterone therapy has become a cornerstone treatment for men with hypogonadism, offering significant benefits such as improved sexual function, mood, muscle mass, and bone density. However, concerns about its cardiovascular safety have historically tempered its use.
Michael Zitzmann, Giulia Rastrelli, Robert D Murray, David Edwards, Yacov Reisman, Preethi Mohan Rao, Alexander Sahi, Thomas Hugh Jones, Alberto Ferlin, Eleni Armeni, Emiliano Corpas, Jann‐Frederik Cremers, Janine David, Stefan Arver, Leen Antonio, Giovanni Corona   +15 more
wiley   +1 more source

Expert system-based application for fatal ventricular arrhythmia risk level estimation based on QT-Interval prolongation

Sebastián García Galán, José Ángel Cabrera, Adam Marchewka, J. E. Muñoz Expósito, Juan de la Torre Cruz, P. Vera‐Candeas, Francisco Javier Serrano, Julio J. Carabias Orti, F.J. Cañadas-Quesada, Raul Mata Campos, N. Ruiz-Reyes, Alfonso Cruz Lendínez   +11 more
openalex   +1 more source

Drug- and non-drug-associated QT interval prolongation.

British Journal of Clinical Pharmacology, 2010
C. van Noord, M. Eijgelsheim, B. Stricker   +2 more
semanticscholar   +1 more source